PUBLISHER: The Business Research Company | PRODUCT CODE: 1970315
PUBLISHER: The Business Research Company | PRODUCT CODE: 1970315
Bioinformatics services encompass a broad spectrum of computational tools, resources, and analyses applied in the realm of bioinformatics. These services involve scrutinizing connections between technical and biological variables within studies, encompassing tasks such as sample metadata assessment, data quality control, and standardization across samples.
The primary categories of bioinformatics services include sequencing services, data analysis, drug discovery services, differential gene expression analysis, database management, and various other specialized bioinformatics services. Sequencing services involve deciphering the exact sequence of nucleotides within a given sample. Specialized domains within bioinformatics services span medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, and forensic biotechnology. The applications of these services are diverse, encompassing genomics, chemoinformatics, drug design, proteomics, transcriptomics, metabolomics, and other fields. End-users of bioinformatics services include academic institutes, research centers, hospitals, clinics, pharmaceutical and biotechnology companies, contract research organizations (CROs), and various other end-user entities.
Tariffs have impacted the bioinformatics services market by increasing costs associated with imported high performance computing systems, data storage infrastructure, and laboratory equipment. Research intensive regions such as North America, Europe, and Asia Pacific have been most affected. These higher costs have influenced budgeting for large scale bioinformatics projects. At the same time, tariffs are encouraging greater adoption of cloud based bioinformatics services. This transition is reducing dependency on physical infrastructure and supporting scalable research workflows.
The bioinformatics services market research report is one of a series of new reports from The Business Research Company that provides bioinformatics services market statistics, including bioinformatics services industry global market size, regional shares, competitors with a bioinformatics services market share, detailed bioinformatics services market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics services industry. This bioinformatics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioinformatics services market size has grown rapidly in recent years. It will grow from $4.72 billion in 2025 to $5.53 billion in 2026 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to growth in genomic sequencing activities, increasing biomedical research funding, expansion of life sciences research, demand for high quality biological data analysis, adoption of computational biology tools.
The bioinformatics services market size is expected to see rapid growth in the next few years. It will grow to $10.55 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to rising precision medicine adoption, growth of omics based research, increasing pharmaceutical R&D investment, expansion of cloud based bioinformatics services, integration of AI in biological data analysis. Major trends in the forecast period include advanced genomic data analysis services, AI driven bioinformatics pipelines, cloud based bioinformatics platforms, integrated multi omics data analysis, customized bioinformatics consulting.
The rising demand for personalised medicine is expected to drive the expansion of the bioinformatics services market in the coming years. Personalised medicine represents a modern approach to healthcare and treatment that considers individual differences in patients' genes, environments, and lifestyles. Bioinformatics plays a crucial role in personalised medicine by identifying genetic variations, predicting disease risks, analysing genomic and proteomic data, and safeguarding sensitive personal health information. For example, in February 2024, the Personalised Medicine Coalition, a US-based non-profit organisation, reported that the FDA approved 16 new personalised therapies for rare disease patients in 2023, up from six in 2022. Consequently, the growing demand for personalised medicine is fueling the growth of the bioinformatics services market.
Leading companies in the bioinformatics services market are concentrating on launching innovative bioinformatics tools that provide advanced solutions for epigenetic data analysis. Bioinformatics tools are specialised software applications and computational resources developed to analyse, interpret, and manage biological data. These advanced tools are designed to meet the needs of research in biology, epigenetics, and healthcare. For instance, in July 2023, FOXO Technologies Inc., a US-based biotechnology company, launched 'Bioinformatics Services', a comprehensive platform offering a suite of innovative bioinformatic tools to accelerate epigenetic data analysis. This state-of-the-art platform enhances the speed and accuracy of data processing, analysis, and interpretation, facilitating deeper insights into complex diseases and expediting research outcomes.
In July 2025, QIAGEN N.V., a Germany-based provider of molecular diagnostics and life science solutions, acquired Genoox Ltd. for an undisclosed amount. Through this acquisition, QIAGEN aims to enhance its clinical genomics portfolio by integrating Genoox's AI-driven variant interpretation technology into its existing bioinformatics ecosystem, thereby improving diagnostic precision, streamlining genomic analysis workflows, and expanding its offerings for hereditary disease and oncology applications. Genoox Ltd., a US-based bioinformatics software company, provides an AI-powered, cloud-based platform for genomic data analysis and interpretation for both clinical and research purposes.
Major companies operating in the bioinformatics services market are QIAGEN Digital Insights; DNAnexus Inc.; Biomax Informatics AG; BGI Group; CD Genomics Inc.; MedGenome Labs Pvt. Ltd.; Fios Genomics Ltd.; Geneva Bioinformatics SA; Accelrys Inc.; Macrogen Inc.; GENEWIZ Inc.; Source BioScience Limited; Microsynth AG; BaseClear B.V.; DNASTAR Inc.; GATC Biotech AG; Partek Incorporated; Seven Bridges Genomics Inc.; Omixon Inc.; BioTeam Inc.; BioBam Bioinformatics S.L.; Biomatters Limited; Genomatix GmbH; DNASTREAM Limited; Genalice B.V.; Golden Helix Inc.; Strand Life Sciences Private Limited
North America was the largest region in the bioinformatics services market in 2025.Europe is expected to be the fastest-growing region in the global bioinformatics services market report during the forecast period. The regions covered in the bioinformatics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioinformatics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bioinformatics services market includes revenues earned by entities through single-cell analysis, proteomics analysis, metabolomics analysis, and epigenetics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioinformatics Services Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bioinformatics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioinformatics services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioinformatics services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.